Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FEN1 | P39748 | 15/20 | 0.41 |
| ▸ | ALOX5AP | P20292 | 14/20 | 0.41 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.39 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.39 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.39 |
| ▸ | GPR88 | Q9GZN0 | 2/20 | 0.38 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.38 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.38 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.38 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.38 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.38 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.38 |
| ▸ | PIM1 | P11309 | 1/20 | 0.37 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.37 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24946644 | 0.90 | ALOX5AP (0.40) | FEN1ALOX5AP | |
| SCHEMBL24946518 | 0.86 | FEN1 (0.40) | FEN1ALOX5AP | |
| SCHEMBL23116071 | 0.85 | PIK3CD (0.38) | FEN1ALOX5APGPR88PIK3CDPDGFRA | |
| SCHEMBL23116111 | 0.85 | PIK3CD (0.38) | FEN1ALOX5APGPR88PIK3CDPDGFRA | |
| SCHEMBL23116070 | 0.85 | PIK3CD (0.38) | FEN1ALOX5APGPR88PIK3CDPDGFRA | |
| SCHEMBL23116237 | 0.85 | GPR88 (0.39) | GPR88PIK3CDPDGFRAPIK3CAPIK3CB | |
| SCHEMBL23116240 | 0.85 | GPR88 (0.39) | GPR88PIK3CDPDGFRAPIK3CAPIK3CB | |
| SCHEMBL29972319 | 0.85 | GPR88 (0.39) | GPR88PIK3CDPDGFRAPIK3CAPIK3CB | |
| SCHEMBL23116234 | 0.85 | GPR88 (0.39) | GPR88PIK3CDPDGFRAPIK3CAPIK3CB | |
| SCHEMBL24946641 | 0.83 | FEN1 (0.40) | FEN1ALOX5AP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230034917-A1 | ION CHANNEL MODULATORS | PRAXIS PRECISION MEDICINES, INC. | 2023-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230034917-A1 | ION CHANNEL MODULATORS | SCN1A, SCN3A, SCN2A | FEN1 4819/4885ALOX5AP 1210/4885TLR9 4869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.